Evidence map›Paper›PMID 35054943›Full record

ReviewInternational journal of molecular sciences2022

DNA Methylation and Non-Coding RNAs during Tissue-Injury Associated Pain.

Jahanzaib Irfan, Muhammad Rizki Febrianto, Anju Sharma, Thomas Rose, Yasamin Mahmudzade, Simone Di Giovanni, Istvan Nagy, Jose Vicente Torres-Perez

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jahanzaib IrfanNociception Group, Department of Surgery and Cancer, Division of Anaesthetics, Pain Medicine and Intensive Care, Chelsea and Westminster Hospital Campus, Imperial College London, 369 Fulham Road, London SW10 9FJ, UK.
Muhammad Rizki FebriantoNociception Group, Department of Surgery and Cancer, Division of Anaesthetics, Pain Medicine and Intensive Care, Chelsea and Westminster Hospital Campus, Imperial College London, 369 Fulham Road, London SW10 9FJ, UK.ORCID 0000-0003-0828-7870
Anju SharmaNociception Group, Department of Surgery and Cancer, Division of Anaesthetics, Pain Medicine and Intensive Care, Chelsea and Westminster Hospital Campus, Imperial College London, 369 Fulham Road, London SW10 9FJ, UK.
Thomas RoseNociception Group, Department of Surgery and Cancer, Division of Anaesthetics, Pain Medicine and Intensive Care, Chelsea and Westminster Hospital Campus, Imperial College London, 369 Fulham Road, London SW10 9FJ, UK.ORCID 0000-0002-2091-688X
Yasamin MahmudzadeNociception Group, Department of Surgery and Cancer, Division of Anaesthetics, Pain Medicine and Intensive Care, Chelsea and Westminster Hospital Campus, Imperial College London, 369 Fulham Road, London SW10 9FJ, UK.ORCID 0000-0003-3602-1025
Simone Di GiovanniDepartment of Brain Sciences, Division of Neuroscience, Imperial College London, E505, Burlington Danes, Du Cane Road, London W12 ONN, UK.ORCID 0000-0003-3154-5399
Istvan NagyNociception Group, Department of Surgery and Cancer, Division of Anaesthetics, Pain Medicine and Intensive Care, Chelsea and Westminster Hospital Campus, Imperial College London, 369 Fulham Road, London SW10 9FJ, UK.
Jose Vicente Torres-PerezDepartment of Brain Sciences, Dementia Research Institute, Imperial College London, 86 Wood Ln, London W12 0BZ, UK.ORCID 0000-0001-6390-9690
Chelsea and Westminster Hospital · GBImperial College London · GBUniversitat de València · ES

Funding

Conselleria d'Innovació, Universitats, Ciència y Societat Digital de la Generalitat Valenciana APOSTD/2021/150Gobierno de España, Ministerio de Universidades Ayudas Maria ZambranoIndonesia Endowment Fund for Education N/AUK Dementia Research Institute N/A
6 · The paper itself

Abstract

While about half of the population experience persistent pain associated with tissue damages during their lifetime, current symptom-based approaches often fail to reduce such pain to a satisfactory level. To provide better patient care, mechanism-based analgesic approaches must be developed, which necessitates a comprehensive understanding of the nociceptive mechanism leading to tissue injury-associated persistent pain. Epigenetic events leading the altered transcription in the nervous system are pivotal in the maintenance of pain in tissue injury. However, the mechanisms through which those events contribute to the persistence of pain are not fully understood. This review provides a summary and critical evaluation of two epigenetic mechanisms, DNA methylation and non-coding RNA expression, on transcriptional modulation in nociceptive pathways during the development of tissue injury-associated pain. We assess the pre-clinical data and their translational implication and evaluate the potential of controlling DNA methylation and non-coding RNA expression as novel analgesic approaches and/or biomarkers of persistent pain.

Indexed as

DNA MethylationEpigenesis, GeneticRNA, UntranslatedAdaptation, BiologicalBiomarkersChronic PainCpG IslandsDiagnosis, DifferentialDisease SusceptibilityGene Expression ProfilingGene Expression RegulationHumansWounds and InjuriesBiomarkersRNA, UntranslatedCpG islandsdorsal root ganglionepigeneticgene transcriptionlncRNAmiRNAneuropathic painnociceptionsiRNAspinal dorsal horn

Identifiers

PMID35054943
PMCPMC8775747
OpenAlexW4205568856

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.